Background: Transseptal puncture (TSP) is commonly performed under fluoroscopic guidance in left atrial ablation procedures. This exposes patients and healthcare professionals to deleterious ionizing radiation. We describe a novel technique for performing TSP non-fluoroscopically using a three-dimensional (3D) mapping system only. The safety and efficacy of this technique is compared to traditional fluoroscopy guided TSP.
INTRODUCTION
Left atrial access following needle puncture through the interatrial septum-transseptal puncture (TSP)-is an essential step in the majority of left heart catheter ablation procedures. [1] [2] [3] Conventionally, TSP is performed under fluoroscopic guidance. 3, 4 Although this allows direct visualization of the transseptal needle/sheath unit and the cardiac silhouette, relevant intra-cardiac structures cannot be identified. Furthermore, fluoroscopy exposes both the patient and the medical staff to potentially deleterious ionizing radiation. [4] [5] [6] [7] To overcome these limitations, TSP can be performed under transesophageal (TOE) or intracardiac (ICE) echocardiography guidance. [8] [9] [10] [11] However, TOE usually requires general anesthesia and the cost of ICE makes its routine use prohibitive in many healthcare systems.
We describe a novel technique for performing non-fluoroscopic TSP using a three-dimensional electro-anatomical mapping system (3D EAM) without the need for peri-operative TOE or ICE. Previous TSP, n (%) 12(60) 8(57) 0.86 P-value < 0.05 considered significant. DCM = dilated cardiomyopathy; IHD = ischemic heart disease; LA = left atrial; LVEF = left ventricular outflow tract; RA = right atrial; SD = standard deviation; TSP = transseptal puncture.
TA B L E 1 Baseline demographics of patients in the nonfluoroscopy
(n = 20) and fluoroscopy (n = 14)
METHODS

Study design
This was a retrospective, single-center, case-control study evaluating the safety and success of non-fluoroscopic TSP (using 3D EAM) compared to conventional fluoroscopic guided TSP. All data presented
were prospectively recorded in our departmental AF ablation registry.
The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institutions human research committees. Prior to the procedure, all patients gave written informed consent.
Study population
Twenty patients (nonfluoroscopy group) undergoing catheter ablation for symptomatic atrial fibrillation/atrial tachycardia underwent TSP guided exclusively by a three-dimensional electro-anatomical mapping system (CARTO 3, Biosense Webster, Diamond Bar, CA, USA). They were compared with 14 patients (fluoroscopy group) undergoing the same ablation procedures, but by conventional fluoroscopic guided TSP. The patients in both groups were well matched for baseline demographics (Table 1) In addition, a decapolar diagnostic catheter (Boston Scientific) was placed within the coronary sinus for fluoroscopically guided procedures. All TSPs were performed using an Endrys Coaxial Needle (Cook Medical Inc.) consisting of a soft dilator housing a blunt outer needle (which can be safely exposed within the superior vena cava) and a sharp, inner stylet ( Figure 1 ).
Technique for performing nonfluoroscopic transseptal puncture
All procedures were performed on uninterrupted anticoagulation For the purposes of data collection, the procedure was performed in a stepwise fashion as follows:
1. The distal 14 cm of the ablation catheter was inserted into the 8 French femoral venous sheath so that it was within the vein.
Following initialization of the CARTO system, the contact force was zeroed and the catheter advanced into the right atrium while maintaining a contact force of less than 15 g. Once atrial electrograms were recorded, the catheter was deflected down on to the cavotricuspid isthmus and respiratory training performed. A respiratory-gated, limited right atrial geometry was 
2.3.3
Exchanging the standard SR0 sheath for a deflectable transseptal sheath without fluoroscopy A circular, 20 pole LassoNav catheter was passed into the left atrium through the SR0 sheath and a geometry collected by fast anatomical mapping. The LassoNav catheter was removed and a 180 cm, 0.038 in J-tipped guidewire passed into the left atrium. The tip of the guidewire was visualized within the left atrium by attaching the pacing cable crocodile clips to the exposed proximal end. The guidewire was passed into one of the left sided pulmonary veins and the SR0 sheath exchanged for a deflectable transseptal sheath. A second transseptal puncture was then performed with the SR0 sheath as described above. Neither TOE nor ICE was used routinely in either group for TSP.
TA B L E 2 Times for transseptal puncture steps and total fluoroscopy times in nonfluoroscopy (NF) and fluoroscopy (F) groups
Process time
Step 1
Step 2
Step 3
Step 4
Step 5
Step 6
Step 7
Step 8
Step 9 The table shows the transeptal puncture steps (Step 1-9) detailed below and the fluoroscopy times in the two groups for each of these steps. The fluoroscopy time is expressed in seconds (mean
is considered significant. SD = standard deviation; SVC = superior vena cava.
Step 1. Right atrial geometry/ catheter insertion in the control group.
Step 2. Insertion long sheath into SVC.
Step 3. Insertion transseptal unit.
Step 4. First transseptal puncture.
Step 5. Exchange transseptal sheath to steerable Agilis sheath.
Step 6. Insertion long sheath into SVC for second transseptal puncture.
Step 7. Insertion transseptal unit.
Step 8. Second transseptal puncture.
Step 9. Left atrial geometry. 
Statistical analyses
All analyses were carried out using SAS version 9.3, statistical software. Continuous data were presented as mean ± SD or median (range) if not normally distributed. Categorical data were reported as a percentage. Continuous data were compared using unpaired t-test (if normally distributed) and Mann-Whitney U test if not normally distributed. Categorical data were compared using Chi-square test. A P-value < 0.05 was considered significant.
RESULTS
Study patients
Twenty patients were included in the nonfluoroscopy group and prospectively compared with 14 patients in the fluoroscopy group.
The two groups were well matched for clinical characteristics (Table 1) .
A total of 32 transseptal punctures were performed in the nonfluoroscopy group versus 25 in the fluoroscopy group. All patients underwent preprocedure TOE except for two patients in each group.
None of the patients who underwent TOE had a demonstrable patent foramen ovale or residual septal perforation from previous TSPs.
Transseptal puncture: Success rate and fluoroscopy times
The transseptal puncture success rate in the nonfluoroscopy group was 88% compared to 96% in the fluoroscopy group (n = 32 versus 25, P = 0.97). The mean fluoroscopy time and dose were significantly lower in the nonfluoroscopy group (0.75 ± 0.50 vs 5.32 ± 3.23 min, P < 0.001; 92.5 ± 60.7 vs 394.3 ± 182.7 min, P < 0.001; Figure 4B and C). Tables 2   and 3 ). However, the total procedure times were not significantly different (non-fluoroscopic TSP procedure time 1763 ± 760 s vs fluoroscopic TSP procedure time 1261 ± 891 s, P = ns, Figure 4A ). Tables 2 and 3 However, the puncture itself was performed non-fluoroscopically.
As shown in
The second patient required fluoroscopy during step 5 since the steerable Agilis sheath could not be advanced across the septum easily (fluoroscopy time <6 s, DAP 21 cGy/cm 2 ).
Procedural complications
There were no significant complications in the fluoroscopic TSP group.
In the non-fluoroscopic group, there was one cardiac tamponade and TSP was unsuccessful in two cases. In the case with cardiac Step 1
Step 9 F 47 ± 57 8 ± 9 7 ± 9 5 4 ± 69 20 ± 34 6 ± 6 8 7 ± 69 24 ± 56
The table shows the average fluoroscopy dose area product ( Gy•cm 2 ) for the transseptal steps (Steps 1-9) as detailed below. Fluoroscopy dose for each step is expressed in Gy•cm 2 (mean ± SD). SD = standard deviation; SVC = superior vena cava.
Step 1. Diagnostic catheter insertion in coronary sinus.
Step 6. Second long sheath into SVC for second transseptal puncture.
Step 9. Left atrial geometry.
tamponade, the first non-fluoroscopic TSP was uncomplicated; however, exchanging the transseptal sheath for the Agilis sheath was difficult. Shortly after the exchange was completed, hypotension and The second patient had aortic valve replacement and no clear drop 
DISCUSSION
Given the expansion of electrophysiology procedures, it is crucial to perform safe TSPs with minimal radiation exposure. Our study demonstrates for the first time, a novel technique for performing TSP safely using a three-dimensional electroanatomical mapping system, without the use of fluoroscopy. Using this technique access to LA was obtained safely in all patients with no significant increase in the complication rate when compared to the fluoroscopic approach.
The main benefit of this approach is near elimination of radiation exposure for the cardiologist and the patient without increasing the procedural risk. This is especially important since the cumulative radiation exposure of cardiologists has been associated with adverse outcomes. [12] [13] [14] Reducing radiation exposure has similar benefits for patients undergoing electrophysiology procedures that require access to the left atrium. 15 Furthermore, the catheter laboratory team does not require lead aprons, which are associated with significant morbidity when worn for long procedures such as complex catheter ablations. [16] [17] [18] [19] Our technique clearly takes longer than the fluoroscopic approach. The CARTO 3 mapping system allows catheter visualization by sending a current down the catheter that creates an electric field around the electrodes within the heart. This is detected by the six patches applied to the patient's torso and the catheter can be visualized as long as it is within a region where a sensor-enabled catheter (eg, the Navistar ablation catheter) has created a current ratio matrix.
In the case of the Endrys needle, there are no bipoles and the midpoint of the exposed part of the needle is therefore seen rather than the tip. We have also used this technique successfully in one case with 
STUDY LIMITATIONS
Limitations of this technique need to be considered. TSP in patients with implantable devices will require minimal fluoroscopy to ensure that the pacing leads are not snared. In patients with previous valve surgery and cardiac rotation, fluoroscopy and TOE guidance may be required. However, the number of such patients in our study was small.
Since the CARTO 3 system only allows visualization of bipolar catheters, the transseptal needle always appears as a linear image, which can be distracting. Recently, our colleagues at the Biosense Webster Haifa Technology Centre (Tel Aviv, Israel) designed an extensible markup language (XML) file that allowed us to define the needle as a unipolar catheter. This changed the needle image to a ball, which was much easier to appreciate. Also to note, when using this technique with alternative mapping systems like Precision (Abbott Medical),
we were able to visualize the tip of the Endrys needle (rather than midpoint) relative to the transseptal apparatus.
Exchanging the transseptal sheath for another remains difficult since the position of the guidewire as visualized within the left atrial geometry changes significantly as the transseptal sheath is retracted.
This is because as more of the guidewire is exposed, its mid-point and image move, increasing the risk of guidewire displacement or looping.
This can make insertion of the new sheath difficult. Designing an insulated guidewire that could be reliably visualized and a sheath with a tip electrode would facilitate this step. The latter will be a feature in the next generation of transseptal sheaths. These developments would enable quick insertion of the transseptal sheath into the SVC in an analogous fashion to the fluoroscopic approach.
CONCLUSIONS
Transseptal punctures can be performed safely and effectively using this non-fluoroscopic approach with the help of 3D electroanatomic mapping systems in the vast majority of patients. Radiation exposure is reduced significantly by using this novel technique for performing transseptal punctures without compromising patient safety. Judicious use of fluoroscopy is warranted in patients with cardiac implantable devices and previous cardiac surgery to ensure patient safety.
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